PT1805192E - Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais - Google Patents

Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais

Info

Publication number
PT1805192E
PT1805192E PT58211251T PT05821125T PT1805192E PT 1805192 E PT1805192 E PT 1805192E PT 58211251 T PT58211251 T PT 58211251T PT 05821125 T PT05821125 T PT 05821125T PT 1805192 E PT1805192 E PT 1805192E
Authority
PT
Portugal
Prior art keywords
analogs
salts
tumor agents
isophosphoramide mustard
isophosphoramide
Prior art date
Application number
PT58211251T
Other languages
English (en)
Portuguese (pt)
Inventor
Morgan Lee
Original Assignee
Dekk Tec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekk Tec Inc filed Critical Dekk Tec Inc
Publication of PT1805192E publication Critical patent/PT1805192E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/222Amides of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT58211251T 2004-10-25 2005-10-25 Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais PT1805192E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US67270705P 2005-04-18 2005-04-18

Publications (1)

Publication Number Publication Date
PT1805192E true PT1805192E (pt) 2013-01-23

Family

ID=35788704

Family Applications (1)

Application Number Title Priority Date Filing Date
PT58211251T PT1805192E (pt) 2004-10-25 2005-10-25 Sais de mostarda de isofosforamida e análogos da mesma como agentes antitumorais

Country Status (17)

Country Link
US (4) US7678778B2 (https=)
EP (3) EP2336140B1 (https=)
JP (1) JP5336082B2 (https=)
KR (2) KR101292026B1 (https=)
CN (3) CN101087800B (https=)
AU (1) AU2005299385B2 (https=)
CA (1) CA2585125C (https=)
DK (2) DK1805192T3 (https=)
ES (2) ES2397165T3 (https=)
HK (1) HK1209752A1 (https=)
IL (3) IL182752A (https=)
NO (1) NO20072478L (https=)
NZ (2) NZ555323A (https=)
PL (1) PL1805192T3 (https=)
PT (1) PT1805192E (https=)
SI (1) SI1805192T1 (https=)
WO (1) WO2006047575A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336140B1 (en) 2004-10-25 2016-01-27 Dekk-Tec, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
MX2009010820A (es) * 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.
NZ601139A (en) * 2008-07-31 2014-02-28 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
AU2010218109B2 (en) 2009-02-24 2015-04-09 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
WO2017044453A1 (en) 2015-09-10 2017-03-16 Becton, Dickinson And Company Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
EP3565520B1 (en) 2017-01-06 2026-02-25 Palvella Therapeutics, Inc. Anhydrous compositions of mtor inhibitors and methods of use
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN209400423U (zh) 2017-09-21 2019-09-17 贝克顿·迪金森公司 横向流测定物、测定物读取器装置和包括其的系统
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
EP3856754A1 (en) * 2018-09-25 2021-08-04 The United States of America, as represented by the Secretary, Department of Health and Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (https=) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
ZA871260B (en) * 1986-02-22 1987-09-30 Asta Werke Ag Chem Fab Novel heterocyclic compounds having a 2-(2-(n,n-bis-(2-chloroethyl)-diamidophosphoryloxy)ethyl)radical
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
CA2130578A1 (en) 1992-04-17 1993-10-28 Geewananda P. Gunawardana Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
DE60007120T2 (de) 1999-05-24 2004-09-16 Southern Research Institute, Birmingham Isophosphoramide-senfgasanalogen und deren verwendung
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
GB2378948B (en) 2000-04-13 2004-11-10 Hsc Res Dev Lp Novel compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
EP2186811A1 (en) 2002-08-23 2010-05-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
EP2336140B1 (en) * 2004-10-25 2016-01-27 Dekk-Tec, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
MX2009010820A (es) 2007-04-06 2010-03-18 Ziopharm Oncology Inc Sales de mostaza isofosforamida y analogos de la misma.
NZ601139A (en) * 2008-07-31 2014-02-28 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Also Published As

Publication number Publication date
IL182752A (en) 2012-09-24
EP2336140A2 (en) 2011-06-22
WO2006047575A3 (en) 2006-08-10
US20060089333A1 (en) 2006-04-27
US7678778B2 (en) 2010-03-16
CA2585125A1 (en) 2006-05-04
AU2005299385B2 (en) 2011-06-16
KR101292026B1 (ko) 2013-08-01
IL211936A0 (en) 2011-05-31
IL182752A0 (en) 2007-07-24
JP5336082B2 (ja) 2013-11-06
HK1100945A1 (en) 2007-11-16
CN104558023A (zh) 2015-04-29
HK1209752A1 (en) 2016-04-08
DK2336140T3 (en) 2016-03-21
EP1805192A2 (en) 2007-07-11
US9346836B2 (en) 2016-05-24
CN103172662A (zh) 2013-06-26
ES2397165T3 (es) 2013-03-05
EP2336139A3 (en) 2012-01-04
US20150152125A1 (en) 2015-06-04
IL211935A0 (en) 2011-05-31
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
JP2008517949A (ja) 2008-05-29
EP2336140A3 (en) 2012-01-11
KR20130041384A (ko) 2013-04-24
US20080267945A1 (en) 2008-10-30
CA2585125C (en) 2014-04-22
EP2336139A2 (en) 2011-06-22
NZ589418A (en) 2012-03-30
AU2005299385A1 (en) 2006-05-04
IL211936A (en) 2012-12-31
ES2565929T3 (es) 2016-04-07
DK1805192T3 (da) 2013-02-04
PL1805192T3 (pl) 2013-03-29
US20130149296A1 (en) 2013-06-13
KR20070121632A (ko) 2007-12-27
NO20072478L (no) 2007-06-25
NZ555323A (en) 2010-12-24
CN101087800B (zh) 2015-01-07
SI1805192T1 (sl) 2013-02-28
WO2006047575A2 (en) 2006-05-04
CN101087800A (zh) 2007-12-12
US8795659B2 (en) 2014-08-05
US8232262B2 (en) 2012-07-31

Similar Documents

Publication Publication Date Title
IL182752A0 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
AP2006003768A0 (en) TetraazabenzoÄeÜazulene derivatives and analogs tehereof
IL189602A0 (en) Indenoisoquinolinone analogs and methods of use thereof
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL185747A0 (en) Use of supplemental assignments
PT1778618E (pt) Síntese de trietilenotetraminas
IL184036A0 (en) Preparation of rosuvastatin
EP1730148A4 (en) USE OF AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS
IL180088A0 (en) Azine-carboxamides as anti-cancer agents
EP1756092A4 (en) NEW INHIBITORS OF RHO-KINASEN
IL176932A0 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
GB0417401D0 (en) Stabilised prostaglandin composition
EP1928489A4 (en) Ghrelin Analogs
IL176922A0 (en) Compositions and methods of use of a-type procyanidins
EP1796676A4 (en) TRANSDERMALE ADMINISTRATION OF PHYCOTOXINES
PL1778621T3 (pl) Wytwarzanie jodiksanolu
EP1945258A4 (en) FDT RELATED COMPOUNDS AND THEIR ANALOGUES
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
PL1740204T3 (pl) Lecznicze zastosowanie alfa-mannozydazy
GB0412584D0 (en) Composition of matter
SI1802209T1 (sl) Oblačilo
IL187948A0 (en) Preparation of rosuvastatin
IL179962A0 (en) Compositions and methods of use of dimer digallates
ZA200706110B (en) Pharmaceutical formulations of gallium salts
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles